tislelizumab
beigene,novartis
novartis announces presentation of positive overall survival data at #wcgic2022 for patients with previously untreated esophageal cancer. #novartisnews #reimaginingmedicine #escc
The official account for @Novartis News & Media Updates. For media inquiries: media.relations@novartis.com. See our community guidelines: https://t.co/b4Kyh4UvNm